Pharmacokinetics of eicosapentaenoic acid in plasma and red blood cells after multiple oral dosing with icosapent ethyl in healthy subjects

By  

Clinical Pharmacology In Drug Development, Vol. 3, Iss. 2, 2014-03 ,pp. : 101-108

John Wiley & Sons Inc

Access to resources Recommend Favorite

Icosapent ethyl for the treatment of hypertriglyceridemia

By Ballantyne Christie M  

Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 10, 2013-07 ,pp. : 1409-1416

Informa Healthcare

Access to resources Recommend Favorite

3,4,5-Tri-O-Galloylquinic Acid Ethyl Ester from Guiera senegalensis

By Bouchet Nathalie   Levesque Joël   Bodo Bernard   Pousset Jean-Louis  

Pharmaceutical Biology (Formerly International Journal of Pharmacognosy), Vol. 36, Iss. 1, 1998-01 ,pp. : 63-65

Informa Healthcare

Access to resources Recommend Favorite

Reduction in Cerebral Atrophy Associated with Ethyl-eicosapentaenoic Acid Treatment in Patients with Huntington's Disease

By Puri BK   Bydder GM   Manku MS   Clarke A   Waldman AD   Beckmann CF  

The Journal of International Medical Research, Vol. 36, Iss. 5, 2008-09 ,pp. : 896-905

Field House Publishing

Access to resources Recommend Favorite

Solid dispersions of the penta-ethyl ester prodrug of diethylenetriaminepentaacetic acid (DTPA): formulation design and optimization studies

By Yang Yu-Tsai   Di Pasqua Anthony J.   Zhang Yong   Sueda Katsuhiko   Jay Michael  

Pharmaceutical Development and Technology, Vol. 19, Iss. 7, 2014-11 ,pp. : 806-812

Informa Healthcare

Access to resources Recommend Favorite